Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

Retrieved on: 2024-03-19 05:14:57

Tags for this article:

Angiogenesis inhibitors

Orphan drugs

Bevacizumab

Vascular endothelial growth factor

Security

Warrant

Intravitreal administration

Branch retinal vein occlusion

Macular degeneration

Private placement

Securities Act

Outlook Therapeutics Inc.

United States

Click the tags to see associated articles and topics

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million. View article details on hiswai:

Excerpt

... Schonfeld Strategic Advisors, Sphera Healthcare, Velan Capital, Woodline Partners LP, and an undisclosed life sciences dedicated investor. BofA ...

Article found on: fox2now.com

View Original Article